Certified by Founder Lodge
Amplitude Ventures
Canada - Montreal, Quebec
INVESTOR
1 Disclosed Funding Rounds $65,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. We work with Canada's most promising healthcare companies that share our vision of
| Company | Date | Round | Raised |
|---|---|---|---|
 Congruence Therapeutics |
March, 07 ,2023 | Series A | $65,000,000 |
 Gandeeva Therapeutics |
January, 31 ,2022 | Series A | $40,000,000 |
 Abdera Therapeutics |
April, 24 ,2023 | Series B | $142,000,000 |
 Evommune |
April, 27 ,2023 | Series B | $50,000,000 |
 Ability Biologics |
December, 07 ,2023 | Seed | $12,000,000 |
 Nomic Bio |
September, 18 ,2024 | Series B | $42,000,000 |
 Fluid Biomed Inc. |
December, 18 ,2024 | Series A | $27,000,000 |
 Reverb Therapeutics |
February, 21 ,2025 | Seed | $21,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
